Alprazolam Orally Disintegrating Tablets — Class II drug recall D-018-2014
Terminated recall by Actavis Elizabeth LLC, reported 2013-12-04, distributed nationwide. Failed Tablet/Capsule Specifications; partial tablet erosion resulting in tablet weights below specification i
| Recall number | D-018-2014 |
|---|---|
| Product type | Drug |
| Classification | Class II |
| Status | Terminated |
| Voluntary or mandated | Voluntary |
| Recalling firm | Actavis Elizabeth LLC, Elizabeth, NJ, United States |
| Recall initiated | 2013-10-09 |
| Classified | 2013-11-22 |
| Reported by FDA | 2013-12-04 |
| Terminated | 2014-11-03 |
| Distributed | Nationwide (US) |
| Quantity | 756 bottles |
| NDC | 00228-4019, 00228-4019-11, 00228-4022, 00228-4022-11, 00228-4024, 00228-4024-11, 00228-4025, 00228-4025-11 |
| Lot numbers | 59380831 |
| Expiration dates | 2014-05-20 |
Product
Alprazolam Orally Disintegrating Tablets, USP 2 mg, 100 count bottles, Rx Only, MFG. BY ACTAVIS ELIZABETH LLC., Elizabeth, NJ, NDC 0228-4025-11
Reason for recall
Failed Tablet/Capsule Specifications; partial tablet erosion resulting in tablet weights below specification in some tablets
Machine access
This record, with every extracted code, the verbatim FDA record and provenance, is available from the recall API: GET https://api.data.aroqon.com/v1/recalls/D-018-2014. Look up any UPC, UDI, NDC or lot with /v1/recalls/lookup?code=…. API docs · free and paid keys.
Source: U.S. Food and Drug Administration enforcement report via openFDA (CC0). Structured by Data Foundry (recall-structuring@2); last changed 2026-09-26. Not affiliated with or endorsed by FDA. Not medical or legal advice.